Improving Predictability and Transparency in DEA and FDA Regulation

Monday, April 7, 2014 - 3:00pm
2123 Rayburn
Witnesses: 

Panel I

 

The Honorable Janet Woodcock, M.D.,

Mr. Joseph T. Rannazzisi

Panel II

 

Dr. Nathan B. Fountain

Mr. John M. Gray

Mr. D. Linden Barber

Ms. Wendy K.D. Selig

Mr. Scott Faber

 

Congress: